Search Results - "Pyrhonen, Seppo" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

by MAGNE TVEIT, Kjell, GUREN, Tormod, FOKSTUEN, Tone, HANSEN, Flemming, HOFSLI, Eva, BIRKEMEYER, Elke, JOHNSSON, Anders, STARKHAMMAR, Hans, YILMAZ, Mette Karen, KELDSEN, Nina, BERIT ERDAL, Anne, DAJANI, Olav, GLIMELIUS, Bengt, DAHL, Olav, CHRISTOFFERSEN, Thoralf, PFEIFFER, Per, SORBYE, Halfdan, PYRHONEN, Seppo, SIGURDSSON, Fridbjorn, KURE, Elin, IKDAHL, Tone, SKOVLUND, Eva
Published in Journal of clinical oncology (20.05.2012)

Get full text

Journal Article

Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer

Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer

by Elzagheid, Adam, MD, PhD, Korkeila, Eija, MD, PhD, Bendardaf, Riyad, MD, PhD, Buhmeida, Abdelbaset, MD, PhD, Heikkilä, Suvi, MD, PhD, Vaheri, Antti, MD, PhD, Syrjänen, Kari, MD, PhD, Pyrhönen, Seppo, MD, PhD, Carpén, Olli, MD, PhD
Published in Human pathology (01.12.2008)

Get full text

Journal Article

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

by Eisen, Tim, Prof, Joensuu, Heikki, Prof, Nathan, Paul D, PhD, Harper, Peter G, FRCP, Wojtukiewicz, Marek Z, Prof, Nicholson, Steve, MD, Bahl, Amit, MD, Tomczak, Piotr, PhD, Pyrhonen, Seppo, Prof, Fife, Kate, MD, Bono, Petri, PhD, Boxall, Jane, RN, Wagner, Andrea, MD, Jeffers, Michael, PhD, Lin, Tiffany, PharmD, Quinn, David I, FRACP
Published in The lancet oncology (01.10.2012)

Get full text

Journal Article

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma

by ELZAGHEID, ADAM, BUHMEIDA, ABDELBASET, LAATO, MATTI, EL-FAITORI, OMRAN, SYRJÄNEN, KARI, COLLAN, YRJÖ, PYRHÖNEN, SEPPO
Published in APMIS : acta pathologica, microbiologica et immunologica Scandinavica (01.07.2012)

Get full text

Journal Article

Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival

Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival

by Nylund, Camilla, Rappu, Pekka, Pakula, Eveliina, Heino, Aleksi, Laato, Laura, Elo, Laura L, Vihinen, Pia, Pyrhönen, Seppo, Owen, Gethin R, Larjava, Hannu, Kallajoki, Markku, Heino, Jyrki
Published in PloS one (21.09.2012)

Get full text

Journal Article

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

by Cunningham, David, Pyrhönen, Seppo, James, Roger D, Punt, Cornelis JA, Hickish, Tamas F, Heikkila, Reino, Johannesen, Tom B, Starkhammar, Hans, Topham, Clare A, Awad, Lucile, Jacques, Christian, Herait, Patrice
Published in The Lancet (British edition) (31.10.1998)

Get full text

Journal Article

Prognostic Evaluation of COX-2 Expression in Renal Cell Carcinoma

Prognostic Evaluation of COX-2 Expression in Renal Cell Carcinoma

by KANKURI-TAMMILEHTO, Minna K, SÖDERSTRÖM, Karl-Ove, PELLINIEMI, Tarja-Terttu, VAHLBERG, Tero, PYRHÖNEN, Seppo O, SALMINEN, Eeva K
Published in Anticancer research (01.07.2010)

Get full text

Journal Article

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome

by Elzagheid, Adam, Algars, Annika, Bendardaf, Riyad, Lamlum, Hanan, Ristamaki, Raija, Collan, Yrjo, Syrjanen, Kari, Pyrhonen, Seppo
Published in World journal of gastroenterology : WJG (21.07.2006)

Get full text

Journal Article

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels

by Vihinen, Pia, Tervahartiala, Taina, Sorsa, Timo, Hansson, Johan, Bastholt, Lars, Aamdal, Steinar, Stierner, Ulrika, Pyrhönen, Seppo, Syrjänen, Kari, Lundin, Johan, Hernberg, Micaela
Published in Cancer Immunology, Immunotherapy (01.02.2015)

Get full text

Journal Article

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence

by Avoranta, Suvi Tuulia
Published in World journal of gastroenterology : WJG (07.09.2012)

Get full text

Journal Article

Serum angiogenin levels predict treatment response in patients with stage IV melanoma

Serum angiogenin levels predict treatment response in patients with stage IV melanoma

by Vihinen, Pia, Kallioinen, Minna, Vuoristo, Meri-Sisko, Ivaska, Johanna, Syrjänen, Kari J, Hahka-Kemppinen, Marjo, Kellokumpu-Lehtinen, Pirkko-Liisa, Pyrhönen, Seppo O
Published in Clinical & experimental metastasis (01.11.2007)

Get full text

Journal Article

Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer

Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer

by Bendardaf, Riyad, Sharif-Askari, Fatemeh Saheb, Sharif-Askari, Narjes Saheb, Syrjänen, Kari, Pyrhönen, Seppo
Published in Anticancer research (01.04.2019)

Get full text

Journal Article

Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha

Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha

by Mattila, Kalle, Raanta, Pirita, Lahtela, Valtteri, Pyrhönen, Seppo, Koskivuo, Ilkka, Vihinen, Pia
Published in Anticancer research (01.11.2018)

Get full text

Journal Article

Diagnosis delay in Libyan female breast cancer

Diagnosis delay in Libyan female breast cancer

by Ermiah, Eramah, Abdalla, Fathi, Buhmeida, Abdelbaset, Larbesh, Entesar, Pyrhönen, Seppo, Collan, Yrjö
Published in BMC research notes (21.08.2012)

Get full text

Journal Article

Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen

Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen

by Bendardaf, Riyad, Sharif-Askari, Fatemeh Saheb, Sharif-Askari, Narjes Saheb, Syrjänen, Kari, Pyrhönen, Seppo
Published in Anticancer research (01.11.2018)

Get full text

Journal Article

Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study

Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study

by Kankuri-Tammilehto, Minna, Perasto, Laura, Pyrhonen, Seppo, Salminen, Eeva
Published in Anticancer research (01.06.2023)

Get full text

Journal Article

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer

by Elzagheid, Adam, Emaetig, Fatma, Alkikhia, Lamia, Buhmeida, Abdelbaset, Syrjänen, Kari, El-Faitori, Omran, Latto, Matti, Collan, Yrjö, Pyrhönen, Seppo
Published in Anticancer research (01.08.2013)

Get full text

Journal Article

High Serum Levels of Matrix Metalloproteinase-9 and Matrix Metalloproteinase-1 Are Associated with Rapid Progression in Patients with Metastatic Melanoma

High Serum Levels of Matrix Metalloproteinase-9 and Matrix Metalloproteinase-1 Are Associated with Rapid Progression in Patients with Metastatic Melanoma

by Nikkola, Johanna, Vihinen, Pia, Vuoristo, Meri-Sisko, Kellokumpu-Lehtinen, Pirkko, Kähäri, Veli-Matti, Pyrhönen, Seppo
Published in Clinical cancer research (15.07.2005)

Get full text

Journal Article

The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients

The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients

by Bendardaf, Riyad, El-Serafi, Ahmed, Syrjänen, Kari, Collan, Yrjö, Pyrhönen, Seppo
Published in Libyan journal of medicine (01.01.2017)

Get full text

Journal Article

Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial

Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial

by Siekkinen, Mervi, Pyrhönen, Seppo, Ryhänen, Anne, Vahlberg, Tero, Leino-Kilpi, Helena
Published in Psycho-oncology (Chichester, England) (01.05.2015)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
Next
[9]